Development and validation of a VHL-associated immune prognostic signature for clear cell renal cell carcinoma
Abstract Background VHL mutation is the most common mutation in clear cell renal cell carcinoma (ccRCC). Here, we developed and validated an immune-related signature to predict the prognosis of ccRCC with VHL mutations. Methods VHL mutation status and RNA expression were analysed in the TCGA dataset...
Uloženo v:
| Hlavní autoři: | , , , , , |
|---|---|
| Médium: | Artigo |
| Jazyk: | Inglês |
| Vydáno: |
BMC
2020-12-01
|
| Edice: | Cancer Cell International |
| Témata: | |
| On-line přístup: | https://doi.org/10.1186/s12935-020-01670-5 |
| Tagy: |
Žádné tagy, Buďte první, kdo vytvoří štítek k tomuto záznamu!
|